RNRMarketResearch.com

NewBorn Screening Market has 11% CAGR, Driven by New Technologies and Newborn Diseases in North America and Asia by 2019

Press Release   •   May 31, 2016 04:14 EDT

The global newborn screening market, estimated at $438.9 million in 2015, is expected to reach $819.6 million by 2019, growing at a CAGR of 11.0% from 2015 to 2019. The market is segmented on the basis of types, technologies, products, and geography. Based on types, the newborn screening market is segmented into dry blood spot test, hearing screen test, and pulse oximetry test. The dry blood spot test market is slated to grow at the highest CAGR owing to the technological advancements due to which new and advanced products are being launched in the market.

Complete report on NewBorn Screening Market spread across 215 Pages, Profiling 10 Companies and Supported with 63 Tables and 13 Figures is now available http://www.reportsnreports.com/reports/290733-newborn-screening-market-by-test-type-dried-blood-spot-hearing-screening-cchd-technology-tandem-mass-spectrometry-immunoassay-enzyme-assay-electrophoresis-pulse-oximeter-instrument-accessories-reagent-assay-kit-global-forecast-to-2019.html .

Newborn screening is a test in which newborns are screened for a panel of inborn diseases that can lead to disabilities or even death. Newborn testing allows early detection and management of congenital disorders, thereby providing a better life to affected infant. This market is driven by several factors which include benefits offered by newborn testing programs, legislations & mandates, technological advancements, government support, & expanding panel of newborn diseases.

Drivers of this Newborn screening market are as follows

  • Benefits Related to Newborn Screening to Propel the Growth of the Market
  • Legislations and Mandates Demands the Implementation of Newborn Screening Program
  • Government Support, An Impetus For Newborn Screening Market
  • Raising Awareness to Trigger the Growth of the Market
  • Technological Innovations to Propel the Growth of the Market
  • Expanding Panel of Newborn Diseases to Bolster the Growth of the Market
  • Rising Incidences of Congenital Heart Defects(Chd)to Propel the CCHD Screening Market

Government initiatives in forms of grants & funds have provided an impetus to market. Technological advancements, which help in introduction of new & innovative devices in the market, are another major factor driving growth of newborn screening market. Relatively untapped Asian market and advent of next-generation sequencing and digital microfluidics technology have opened an array of opportunities for market to grow. However, factors like lack of trained professional infrastructure and socio-economical barriers may restrain the growth of this market.

Interested in this report, Get sample copy of this research now

http://www.reportsnreports.com/contacts/requestsample.aspx?name=290733 .

Newborn screening market includes instruments, reagents, and assay kits. Instruments market accounts for largest share of global products market, followed by reagents and assay kits. high share of instruments market can be attributed to wide usage of newborn screening devices across globe.

The prominent players in the newborn screening market are AB SCIEX (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), Covidien PLC (Ireland), GE Life Sciences (U.K.), Masimo Corporation (U.S.), Natus Medical Inc. (U.S.), PerkinElmer Inc. (U.S.), Trivitron Healthcare (India), and Waters Corporation (U.S.).

Click now for more Details, Queries, Discount and Other Information on this study “NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=290733 .

Based on technologies, the market is subdivided into tandem mass spectroscopy, electrophoresis, enzyme and immunoassays, DNA-based assays, hearing screen technology, and pulse oximetry. The tandem mass spectroscopy market is expected to witness the highest growth. This high growth can be attributed to time-effectiveness and cost effectiveness provided by mass spectrometry as compared to the enzyme assays and immunoassays technology. These advantages are the major reasons for the growth of this market.

About Us:

ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@reportsandreports.com